Correction to: Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment
1 Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, China.
2 Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China.
3 Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China. shirley4444@gmail.com.
4 Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China.
5 Department of Respiratory, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China.
6 Department of thoracic surgery, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China.
7 Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Nanjing, China. mashenglin@medmail.com.cn.
The affiliation of first author (Lucheng Zhu) should be Department of Oncology, Hangzhou Cancer Hospital and Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University.